Cargando…
Phase 1/2 study of topical submicron particle paclitaxel for cutaneous metastases of breast cancer
PURPOSE: This Phase 1/2 study evaluated safety and efficacy of a topical submicron particle paclitaxel (SPP) in an anhydrous ointment base (SOR007), primarily in breast cancer patients with cutaneous metastases (CM). METHODS: One of three concentrations of SOR007 SPP (0.15%, 1.0%, or 2.0%) was appli...
Autores principales: | Lacouture, Mario E., Goldfarb, Shari B., Markova, Alina, Chawla, Sant P., Dewnani, Karan, Iacobucci, Marc, Lang, Julie E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167189/ https://www.ncbi.nlm.nih.gov/pubmed/35471470 http://dx.doi.org/10.1007/s10549-022-06584-6 |
Ejemplares similares
-
Pharmacokinetic Profile of Inhaled Submicron Particle Paclitaxel (NanoPac(®)) in a Rodent Model
por: Verco, James, et al.
Publicado: (2019) -
Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgery
por: Mullany, Sally, et al.
Publicado: (2020) -
Local administration of submicron particle paclitaxel to solid carcinomas induces direct cytotoxicity and immune-mediated tumoricidal effects without local or systemic toxicity: preclinical and clinical studies
por: Verco, Shelagh, et al.
Publicado: (2020) -
Optomechanical crystals for spatial sensing of submicron sized particles
por: Navarro-Urrios, D., et al.
Publicado: (2021) -
2043: Pharmacokinetic prediction of paclitaxel-induced peripheral neuropathy
por: Hertz, Daniel L., et al.
Publicado: (2018)